brandcomms Archive

Icon commits $200,000 to Peter’s Project Foundation survivorship program for local cancer patients

Warrnambool cancer community organisation, Peter’s Project, this week received a donation of $50,000 from Icon Group as part of four-year pledge to support their unique cancer survivorship program. The commitment will see a total of $200,000 invested in the program over the next four years by the local radiation oncology provider. Icon’s donation matches funds …

Icon signs agreement with leading Vietnam hospitals

Icon Group, has signed a milestone agreement at this week’s ASEAN-Australia Summit to deliver cancer care infrastructure and technology in Vietnam. The agreement comes off the back of Icon’s growing Asian footprint and will provide the local cancer community with increased access to comprehensive care close to home. The agreement was confirmed on 16th March, …

Bringing comprehensive cancer care to Mackay, Queensland

On 9th February 2018, a state-of-the art Icon Cancer Centre officially opened in Mackay, bringing all aspects of cancer care under one roof from chemotherapy to radiation therapy and treatment for blood disorders. The centre will ensure local people affected by cancer can now receive comprehensive care on their door step. Mayor Greg Williamson comments, …

Icon Cancer Centre officially opens at The Valley Private Hospital, Melbourne

The new Icon Cancer Centre at The Valley was officially opened today by Monash Council, Mayor Paul Klisaris. The state-of-the-art centre offers the local community of Mulgrave world-class radiation therapy treatment in a friendly and supportive environment for patients and their loved ones. The centre is equipped with the most advanced cutting-edge technology suitable for …

Icon Group brings Australian-first radiation technology to Queensland

A Queensland patient has become the first person in Australia to be treated with world-leading radiation therapy following the installation of Australasia’s first Varian Halcyon™ system to the Radiation Oncology Centre (ROC) in Toowoomba by Brisbane-based Icon Group. The new state-of-the-art Halcyon system offers pioneering technology to streamline and simplify every aspect of a patient’s …

Epworth Radiation Oncology [ERO] services to transition to Icon Group

Icon Group and Epworth recently reached an agreement to transition the Epworth Radiation Oncology services in Victoria to Icon. This includes the radiation oncology services at Epworth Richmond, Epworth Freemasons and the public service delivered by ERO at the South West Regional Cancer Centre in Warrnambool. The agreement follows a detailed review of Epworth’s …

Icon Group announces Australian-first collaboration with IBM Watson Health

IBM Watson Health has announced it will partner with Icon Group to bring Watson for Oncology to Australia for the first-time. The cognitive computing platform, Watson for Oncology, will be made available to oncologists within Icon Group’s Australian network, enabling them to access the massive volumes of cancer research and literature available across the globe. …

New Investors for Icon Group

A consortium of Goldman Sachs Principal Investment Area (GS PIA), QIC and Pagoda Investments (Pagoda) have signed an agreement to acquire a majority interest in Icon Group (Icon) Australia’s fastest growing cancer care provider. The acquisition is subject to shareholder approval. The investment will enhance Australia’s position as a provider of outstanding oncology care by …

Icon Group and Healthscope bring comprehensive cancer care closer to Tasmanian patients

Icon Group today announced the opening of a comprehensive cancer care facility close to Healthscope’s Hobart Private Hospital – the first private cancer centre in Tasmania. This centre is part of Icon and Healthscope’s partnership to increase access to radiation oncology for patients across seven Healthscope hospitals. The Icon Cancer Centre offers both chemotherapy and …

Slade Health broadens into antibiotic compounding

Slade Health, part of Icon Group, has acquired the antibiotic compounding business mobiLIFE, including the mobiLIFE compounding facility in Morisset New South Wales. Slade Managing Director, David Slade says the purchase of mobiLIFE’s antibiotic compounding arm adds to Slade Health’s current compounding and TGA-licensed facilities. “This is an exciting time for Slade. We are constantly …